Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Weighs In On E-Prescribing: Pricing Granularity Critical

Executive Summary

The level of drug pricing granularity available to health care providers via electronic prescribing systems is one key issue to be resolved in setting standards for e-prescribing under Medicare

You may also be interested in...



Medicare E-Prescribing Rule Proposes “Foundation Standards” For Jan. 1

Electronic prescribing systems used under Medicare Part D would be required to include information about comparative copayments under HHS' draft e-prescribing standards rule

Medicare E-Prescribing Rule Proposes “Foundation Standards” For Jan. 1

Electronic prescribing systems used under Medicare Part D would be required to include information about comparative copayments under HHS' draft e-prescribing standards rule

Medicare Card “Easy As 1-2-3,” CMS Says; Program Enhancements Continue

The Centers for Medicare & Medicaid Services is tackling the perception that the Medicare drug discount card program is too confusing for beneficiaries with the message that enrolling is as easy as "one, two, three.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel